Price Target Update on Infosys Limited (NYSE:INFY)

Infosys Limited (NYSE:INFY) stock is expected to deviate a maximum of $1.48 from the average target price of $20.18 for the short term period. 6 Street Experts have initiated coverage on the stock with the most promising target being $22 and the most muted being $18.

Other Equity analysts have also commented on the company shares. Brokerage firm Goldman Sachs upgrades its rating on Infosys Limited (NYSE:INFY). The shares have been rated Buy. Previously, the analysts had a Neutral rating on the shares. The rating by the firm was issued on May 26, 2016.

Infosys Limited (NYSE:INFY): stock turned positive on Thursday. Though the stock opened at $18.84, the bulls momentum made the stock top out at $18.99 level for the day. The stock recorded a low of $18.77 and closed the trading day at $18.98, in the green by 2.15%. The total traded volume for the day was 5,260,950. The stock had closed at $18.58 in the previous days trading.

The company shares have rallied 15.19% from its 1 Year high price. On Apr 15, 2016, the shares registered one year high at $20.47 and the one year low was seen on Jul 9, 2015. The 50-Day Moving Average price is $18.73 and the 200 Day Moving Average price is recorded at $17.89.

Infosys Limited is engaged in consulting, technology, outsourcing and next-generation services. The Companys solutions include application development and maintenance, independent validation services, infrastructure management, engineering services comprising product engineering and life cycle solutions and business process management; Management Consulting, enterprise solutions and package implementation, systems integration and business intelligence; Products, business platforms and solutions, and technologies, such as cloud computing, enterprise mobility, digital, big data and analytics. Its segments are Financial Services and Insurance, Manufacturing, Energy and utilities, Communication and Services, Retail, Consumer packaged goods and Logistics, Life Sciences and Healthcare, and Growth Markets.

Leave a Reply

Get Pre-Market Alerts!

Get Pre-Market Analysts' Upgrades, Downgrades, Earnings & Initiations with our FREE daily email newsletter.